|
KMID : 1225720170090010079
|
|
Allergy, Asthma & Immunology Research : AAIR
2017 Volume.9 No. 1 p.79 ~ p.84
|
|
|
Validation of a Rapid, Robust, Inexpensive Screening Method for Detecting the HLA-B*58:01 Allele in the Prevention of Allopurinol-Induced Severe Cutaneous Adverse Reactions
|
|
Dinh Van Nguyen
Christopher Vida
Hieu Chi Chu
Richard Fulton
Jamma Li
Suran L Fernando
|
|
|
Abstract
|
|
|
|
The HLA B*58:01 allele has been worldwide reported as a pharmacogenetic susceptibility to allopurinol-induced severe cutaneous adverse reactions (SCARs). To prevent these life-threatening conditions, the American College of Rheumatology hingly recommended that the HLA-B*58:01 be screened prior to the initiation of allopurinol therapy. Therefore, we developed a rapid, robust, inexpensive screening method using SYBR® Green real time PCR to detect the HLA-B*58:01 allele. A total of 119 samples were tested. The assay has a sensitivity of 100% (95% CI: 69.15%-100%), a specificity of 100% (95% CI: 96.67%-100%), a positive predictive value of 100% (95% CI: 69.15%-100%) and a negative predictive value of 100% (95% CI: 96.67%-100%). HLA-B*58:01 genotyping results showed 100% agreement with those obtained from Luminex SSO/SBT/SSP. The lowest limit of detection of this method is 0.8 ng/μL of DNA. The unit cost of the test is only $3.8 USD. This novel screening test using SYBR® real time PCR would be appropriate to identify individuals with the HLA-B*58:01 allele for the prevention of allopurinol-induced SCARs.
|
|
|
KEYWORD
|
|
|
Allopurinol hypersensitivity, HLA-B antigens, real time polymerase chain reaction, Stevens Johnson syndrome, toxic epidermal necrolysis, drug reactions with eosinophilia and systemic symptoms, severe cutaneous adverse reactions
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
   
|